Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications (Q38309549)

2 September 2017

1 reference

title

Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications (English)

1 reference

2 September 2017

1 reference

1 reference

Ignace B Vergote

1

1 reference

2 September 2017

Christian Marth

series ordinal

2

1 reference

2 September 2017

Robert L Coleman

series ordinal

3

1 reference

2 September 2017

1 March 2015

1 reference

Cancer and Metastasis Reviews

2 September 2017

1 reference

2 September 2017

34

1 reference

2 September 2017

1

1 reference

2 September 2017

41-52

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-014-9539-8

2 September 2017

0 references

cites work

Compartmentalization of Mammalian folate-mediated one-carbon metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Physiology of folate and vitamin B12 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate status in various pathophysiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Mechanisms of membrane transport of folates into cells and across epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Membrane transport of folates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

The folate receptor: what does it promise in tissue-targeted therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Expression of folate transporters in human placenta and implications for homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Dietary folates and cancer risk in a network of case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate and colorectal cancer: an evidence-based critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate receptor α associated with triple-negative breast cancer and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

The human proton-coupled folate transporter: Biology and therapeutic applications to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate receptor alpha as a tumor target in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

A step further in understanding the biology of the folate receptor in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Androgen activation of the folate receptor α gene through partial tethering of the androgen receptor by C/EBPα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Overexpression of folate binding protein in ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

The absence of caveolin-1 increases proliferation and anchorage- independent growth by a Rac-dependent, Erk-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Mechanisms of motility in metastasizing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Clinical translation of folate receptor-targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate and folate receptor alpha antagonists mechanism of action in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Enhanced uptake and cytotoxity of folate-conjugated mitoxantrone-loaded micelles via receptor up-regulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Tumor detection using folate receptor-targeted imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

Targeting therapeutic and imaging agents to folate receptor positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9539-8

10.1007/S10555-014-9539-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference